Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Net Income: 2021-2025

Historic Net Income for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$196,000.

  • Immunocore Holdings' Net Income fell 102.24% to -$196,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.3 million, marking a year-over-year increase of 37.83%. This contributed to the annual value of -$51.1 million for FY2024, which is 7.60% up from last year.
  • Per Immunocore Holdings' latest filing, its Net Income stood at -$196,000 for Q3 2025, which was up 98.10% from -$10.3 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Net Income high stood at $8.7 million for Q3 2024, and its period low was -$52.6 million during Q4 2021.
  • Its 3-year average for Net Income is -$10.2 million, with a median of -$11.6 million in 2024.
  • Per our database at Business Quant, Immunocore Holdings' Net Income soared by 864.24% in 2024 and then tumbled by 102.24% in 2025.
  • Over the past 4 years, Immunocore Holdings' Net Income (Quarterly) stood at -$52.6 million in 2021, then reached -$19.7 million in 2023, then dropped by 20.48% to -$23.8 million in 2024, then crashed by 102.24% to -$196,000 in 2025.
  • Its last three reported values are -$196,000 in Q3 2025, -$10.3 million for Q2 2025, and $5.0 million during Q1 2025.